Investing Profile

Peter Kolchinsky

VCInvestor

Managing Partner at Managing Partner

racap.comBoston, Massachusetts
Photo of Peter Kolchinsky, Managing Partner at RA Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
RA Capital Managing Partner
$100K - $5.0M
$1.5M
25
CompanyStageDateRound SizeTotal Raised
Nimbus Therapeutics
Venture RoundSep 2022$130M
Venture RoundJul 2021$110M
Venture RoundOct 2020$60M
$430M
Co-investors: Bruce Booth (Atlas Venture), Laura Stoppel (RA Capital), Vicki Sato (ARCH Venture Partners), Nikola Trbovic (Pfizer Venture Investments)
SeLux Diagnostics
Series CFeb 2022$50M
$50M
Freenome
Series DDec 2021$300M
Series CAug 2020$270M
Series BJul 2019$160M
$800M
Co-investors: Amir Nashat (Polaris Partners), Jeffrey Schwartz (Bain Capital Life Sciences), Vasudev Bailey (Artis Ventures (AV)), Bill Maris (Section 32), Chris Leiter (Atria Ventures), Skip Fleshman (Asset Management Ventures)
ARS Pharmaceuticals
Series DAug 2021$55M
$55M
Invivyd
Series CApr 2021$340M
$470M
Co-investors: Ajay Royan (Mithril Capital Management)
Icosavax
Series BApr 2021$100M
$150M
Co-investors: Mark McDade (Qiming Venture Partners USA)
Kinnate Biopharma
Series CAug 2020$98M
$170M
Co-investors: Carl Gordon (OrbiMed), Michael Rome (Foresite Capital), Brett Zbar (Foresite Capital)
Novavax
Post-IPO EquityJun 2020$200M
$200M